[1]
|
Velarde Ruiz-Velasco, J.A., Aldana-Ledesma, J.M., Ibarra-Estrada, M.A., Aguirre Díaz, S.A., Fernández-Ramírez, J.A., Cárdenas-Lara, F., et al. (2017) Clinical and Endoscopic Features in Patients with Hospital-Acquired Diarrhea Associated with Clostridium difficile Infection. Revista de Gastroenterología de México (English Edition), 82, 301-308. https://doi.org/10.1016/j.rgmxen.2017.08.002
|
[2]
|
Bartlett, J.G. (1994) Clostridium difficile: History of Its Role as an Enteric Pathogen and the Current State of Knowledge about the Organism. Clinical Infectious Diseases, 18, S265-S272. https://doi.org/10.1093/clinids/18.Supplement_4.S265
|
[3]
|
Montazeri, N., Liu, D. and Janes, M. (2015) Occurrence of Toxigenic Clostridium difficile in Louisiana Oysters (Crassostrea virginica) and Environmental Waters. Food and Nutrition Sciences, 6, 1065-1070. https://doi.org/10.4236/fns.2015.611110
|
[4]
|
Peterson, L.R., Mehta, M.S., Patel, P.A., Hacek, D.M., Harazin, M., Nagwekar, P.P., et al. (2011) Laboratory Testing for Clostridium difficile Infection: Light at the End of the Tunnel. American Journal of Clinical Pathology, 136, 372-380. https://doi.org/10.1309/AJCPTP5XKRSNXVIL
|
[5]
|
Voth, D.E. and Ballard, J.D. (2005) Clostridium difficile Toxins: Mechanism of Action and Role in Disease. Clinical Microbiology Reviews, 18, 247-263. https://doi.org/10.1128/CMR.18.2.247-263.2005
|
[6]
|
Pruitt, R.N. and Lacy, D.B. (2012) Toward a Structural Understanding of Clostridium difficile Toxins A and B. Frontiers in Cellular and Infection Microbiology, 2, Article No. 28. https://doi.org/10.3389/fcimb.2012.00028
|
[7]
|
Zhang, L.-H., Dong, D.-F., Jiang, C. and Peng, Y.-B. (2012) Toxin Detection and Ribotyping of Nosocomial Clostridium difficile Strains. Journal of Shanghai Jiaotong University (Medical Science), 32, 1436-1439.
|
[8]
|
Riegler, M., Sedivy, R., Pothoulakis, C., Hamilton, G., Zacherl, J., Bischof, G., et al. (1995) Clostridium difficile Toxin B Is More Potent than Toxin A in Damaging Human Colonic Epithelium in Vitro. Journal of Clinical Investigation, 95, 2004-2011. https://doi.org/10.1172/JCI117885
|
[9]
|
Tam, J., Beilhartz, G.L., Auger, A., Gupta, P., Therien, A.G. and Melnyk, R.A. (2015) Small Molecule Inhibitors of Clostridium difficile Toxin B-Induced Cellular Damage. Chemistry & Biology, 22, 175-185. https://doi.org/10.1016/j.chembiol.2014.12.010
|
[10]
|
Di Bella, S., Ascenzi, P., Siarakas, S., Petrosillo, N. and Di Masi, A. (2016) Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins, 8, Article No. 134. https://doi.org/10.3390/toxins8050134
|
[11]
|
Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, L.C., et al. (2010) Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control & Hospital Epidemiology, 31, 431-455. https://doi.org/10.1086/651706
|
[12]
|
Peláez, T., Alcalá, L., Alonso, R., Rodríguez-Créixems, M., García-Lechuz, J.M. and Bouza, E. (2002) Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin. Antimicrobial Agents and Chemotherapy, 46, 1647-1650. https://doi.org/10.1128/AAC.46.6.1647-1650.2002
|
[13]
|
Peláez, T., Cercenado, E., Alcalá, L., Marín, M., Martín-López, A., Martínez-Alarcón, J., et al. (2008) Metronidazole Resistance in Clostridium difficile Is Heterogeneous. Journal of Clinical Microbiology, 46, 3028-3032. https://doi.org/10.1128/JCM.00524-08
|
[14]
|
Johnson, S., Sanchez, J.L. and Gerding, D.N. (2000) Metronidazole Resistance in Clostridium difficile. Clinical Infectious Diseases, 31, 625-626. https://doi.org/10.1086/313955
|
[15]
|
Louie, T.J., Miller, M.A., Mullane, K.M., Weiss, K., Lentnek, A., Golan, Y., et al. (2011) Fidaxomicin versus Vancomycin for Clostridium difficile Infection. New England Journal of Medicine, 364, 422-431. https://doi.org/10.1056/NEJMoa0910812
|
[16]
|
Theriot, C.M., Koenigsknecht, M.J., Carlson Jr., P.E., Hatton, G.E., Nelson, A.M., Li, B., et al. (2014) Antibiotic-Induced Shifts in the Mouse Gut Microbiome and Metabolome Increase Susceptibility to Clostridium difficile Infection. Nature Communications, 5, Article No. 3114. https://doi.org/10.1038/ncomms4114
|
[17]
|
Vedantam, G., Clark, A., Chu, M., McQuade, R., Mallozzi, M. and Viswanathan, V.K. (2012) Clostridium difficile Infection: Toxins and Non-Toxin Virulence Factors, and Their Contributions to Disease Establishment and Host Response. Gut Microbes, 3, 121-134. https://doi.org/10.4161/gmic.19399
|
[18]
|
Keel, M.K. and Songer, J.G. (2007) The Distribution and Density of Clostridium difficile Toxin Receptors on the Intestinal Mucosa of Neonatal Pigs. Veterinary Pathology, 44, 814-822. https://doi.org/10.1354/vp.44-6-814
|
[19]
|
Carter, G.P., Lyras, D., Allen, D.L., Mackin, K.E., Howarth, P.M., O’Connor, J.R., et al. (2007) Binary Toxin Production in Clostridium difficile Is Regulated by CdtR, A LytTR Family Response Regulator. Journal of Bacteriology, 189, 7290-7301. https://doi.org/10.1128/JB.00731-07
|
[20]
|
Zheng, Y.-J. and Zhang, G.-C. (2011) Clostridium difficile Infection in Children. Journal of Clinical Pediatrics, 29, 501-505.
|
[21]
|
Carter, G.P., Chakravorty, A., Pham Nguyen, T.A., Mileto, S., Schreiber, F., Li, L., et al. (2015) Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections. MBio, 6, Article No. e00551. https://doi.org/10.1128/mBio.00551-15
|
[22]
|
Bobo, L.D., El Feghaly, R.E., Chen, Y.S., Dubberke, E.R., Han, Z., Baker, A.H., et al. (2013) MAPK-Activated Protein Kinase 2 Contributes to Clostridium difficile-As- sociated Inflammation. Infection and Immunity, 81, 713-722. https://doi.org/10.1128/IAI.00186-12
|
[23]
|
Kelly, C.P., Becker, S., Linevsky, J.K., Joshi, M.A., O’Keane, J.C., Dickey, B.F., et al. (1994) Neutrophil Recruitment in Clostridium difficile Toxin A Enteritis in the Rabbit. Journal of Clinical Investigation, 93, 1257-1265. https://doi.org/10.1172/JCI117080
|
[24]
|
Huang, J., Kelly, C.P., Bakirtzi, K., Villafuerte Gálvez, J.A., Lyras, D., Mileto, S.J., Larcombe, S., et al. (2019) Clostridium difficile Toxins Induce VEGF-A and Vascular Permeability to Promote Disease Pathogenesis. Nature Microbiology, 4, 269-279. https://doi.org/10.1038/s41564-018-0300-x
|
[25]
|
Chen, P., Tao, L., Wang, T., Zhang, J., He, A., Lam, K.H., Liu, Z., He, X., Perry, K., Dong, M. and Jin, R. (2018) Structural Basis for Recognition of Frizzled Proteins by Clostridium difficile Toxin B. Science, 360, 664-669. https://doi.org/10.1126/science.aar1999
|
[26]
|
Tao, L., Zhang, J., Meraner, P., Tovaglieri, A., Wu, X., et al. (2016) Frizzled Proteins Are Colonic Epithelial Receptors for C. Difficile Toxin B. Nature, 538, 350-355. https://doi.org/10.1038/nature19799
|
[27]
|
Yuan, P., Zhang, H., Cai, C., Zhu, S., Zhou, Y., et al. (2015) Chondroitin Sulfate Proteoglycan 4 Functions as the Cellular Receptor for Clostridium difficile Toxin B. Cell Research, 25, 157-168. https://doi.org/10.1038/cr.2014.169
|
[28]
|
LaFrance, M.E., Farrow, M.A., Chandrasekaran, R., Sheng, J., Rubin, D.H. and Lacy, D.B. (2015) Identification of an Epithelial Cell Receptor Responsible for Clostridium difficile TcdB-Induced Cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 112, 7073-7078. https://doi.org/10.1073/pnas.1500791112
|
[29]
|
Gupta, P., Zhang, Z., Sugiman-Marangos, S.N., Tam, J., Raman, S., et al. (2017) Functional Defects in Clostridium difficile TcdB Toxin Uptake Identify CSPG4 Receptor-Binding Determinants. Journal of Biological Chemistry, 292, 17290-17301. https://doi.org/10.1074/jbc.M117.806687
|
[30]
|
Terada, N., Ohno, N., Murata, S., Katoh, R., Stallcup, W.B. and Ohno, S. (2006) Immunohistochemical Study of NG2 Chondroitin Sulfate Proteoglycan Expression in the Small and Large Intestines. Histochemistry and Cell Biology, 126, 483-490. https://doi.org/10.1007/s00418-006-0184-3
|
[31]
|
Gregorieff, A. and Clevers, H. (2005) Wnt Signaling in the Intestinal Epithelium: From Endoderm to Cancer. Genes & Development, 19, 877-890. https://doi.org/10.1101/gad.1295405
|
[32]
|
Nusse, R. and Clevers, H. (2017) Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell, 169, 985-999. https://doi.org/10.1016/j.cell.2017.05.016
|
[33]
|
Qa’Dan, M., Ramsey, M., Daniel, J., Spyres, L.M., Safiejko-Mroczka, B., Ortiz-Leduc, W., et al. (2002) Clostridium difficile Toxin B Activates Dual Caspase-Dependent and Caspase-Independent Apoptosis in Intoxicated Cells. Cellular Microbiology, 4, 425-434. https://doi.org/10.1046/j.1462-5822.2002.00201.x
|
[34]
|
Li, S., Shi, L., Yang, Z. and Feng, H. (2013) Cytotoxicity of Clostridium difficile Toxin B Does Not Require Cysteine Protease-Mediated Autocleavage and Release of the Glucosyltransferase Domain into the Host Cell Cytosol. Pathogens and Disease, 67, 11-18. https://doi.org/10.1111/2049-632X.12016
|
[35]
|
Kreimeyer, I., Euler, F., Marckscheffel, A., Tatge, H., Pich, A., et al. (2011) Autoproteolytic Cleavage Mediates Cytotoxicity of Clostridium difficile Toxin A. Naunyn- Schmiedeberg’s Archives of Pharmacology, 383, 253-262. https://doi.org/10.1007/s00210-010-0574-x
|
[36]
|
Lanis, J.M., Hightower, L.D., Shen, A. and Ballard, J.D. (2012) TcdB from Hypervirulent Clostridium difficile Exhibits Increased Efficiency of Autoprocessing. Molecular Microbiology, 84, 66-76. https://doi.org/10.1111/j.1365-2958.2012.08009.x
|
[37]
|
Chumbler, N.M., Farrow, M.A., Lapierre, L.A., Franklin, J.L., Haslam, D.B., Goldenring, J.R. and Lacy, D.B. (2012) Clostridium difficile Toxin B Causes Epithelial Cell Necrosis through an Autoprocessing-Independent Mechanism. PLoS Pathogens, 8, Article ID: e1003072. https://doi.org/10.1371/journal.ppat.1003072
|
[38]
|
Ng, J., Hirota, S.A., Gross, O., Li, Y., Ulke-Lemee, A., et al. (2010) Clostridium difficile Toxin-Induced Inflammation and Intestinal Injury Are Mediated by the Inflammasome. Gastroenterology, 139, 542-552.e3. https://doi.org/10.1053/j.gastro.2010.04.005
|
[39]
|
Bravo, R., Frank, R., Blundell, P.A. and Macdonald-Bravo, H. (1987) Cyclin/PCNA Is the Auxiliary Protein of DNA Polymerase-Delta. Nature, 326, 515-517. https://doi.org/10.1038/326515a0
|
[40]
|
Kannouche, P.L., Wing, J. and Lehmann, A.R. (2004) Interaction of Human DNA Polymerase Eta with Monoubiquitinated PCNA: A Possible Mechanism for the Polymerase Switch in Response to DNA Damage. Molecular Cell, 14, 491-500. https://doi.org/10.1016/S1097-2765(04)00259-X
|
[41]
|
Bravo, R. and Macdonald-Bravo, H. (1987) Existence of Two Populations of Cyclin/proliferating Cell Nuclear Antigen during the Cell Cycle: Association with DNA Replication Sites. Journal of Cell Biology, 105, 1549-1554. https://doi.org/10.1083/jcb.105.4.1549
|
[42]
|
Danova, M., Riccardi, A., Giordano, M., Girino, M., Mazzini, G., Dezza, L., et al. (1988) Cell Cycle-Related Proteins: A Flow Cytofluorometric Study in Human Tumors. Biology of the Cell, 64, 23-28. https://doi.org/10.1016/0248-4900(88)90089-5
|
[43]
|
Jin, E.H., Lee, D.H., Jung, S.A., Shim, K.N., Seo, J.Y., Kim, N., et al. (2015) Clinicopathologic Factors and Molecular Markers Related to Lymph Node Metastasis in Early Gastric Cancer. World Journal of Gastroenterology, 21, 571-577. https://doi.org/10.3748/wjg.v21.i2.571
|
[44]
|
Wang, L., Kong, W., Liu, B. and Zhang, X. (2018) Proliferating Cell Nuclear Antigen Promotes Cell Proliferation and Tumorigenesis by Up-Regulating STAT3 in Non-Small Cell Lung Cancer. Biomedicine & Pharmacotherapy, 104, 595-602. https://doi.org/10.1016/j.biopha.2018.05.071
|
[45]
|
Ma, S., Yang, J., Li, J. and Song, J. (2016) The Clinical Utility of the Proliferating Cell Nuclear Antigen Expression in Patients with Hepatocellular Carcinoma. Tumor Biology, 37, 7405-7412. https://doi.org/10.1007/s13277-015-4582-9
|
[46]
|
Sheen-Chen, S.M., Ho, H.T., Chen, W.J. and Eng, H.L. (2003) Obstructive Jaundice Alters Proliferating Cell Nuclear Antigen Expression in Rat Small Intestine. World Journal of Surgery, 27, 1161-1164. https://doi.org/10.1007/s00268-003-6992-x
|
[47]
|
Ohmori, Y., Schreiber, R.D. and Hamilton, T.A. (1997) Synergy Between Interferon-Gamma and Tumor Necrosis Factor-Alpha in Transcriptional Activation Is Mediated by Cooperation Between Signal Transducer and Activator of Transcription 1 and Nuclear Factor κB. Journal of Biological Chemistry, 272, 14899-14907. https://doi.org/10.1074/jbc.272.23.14899
|
[48]
|
De Nardo, D.G. and Coussens, L.M. (2007) Inflammation and Breast Cancer. Balancing Immune Response: Crosstalk between Adaptive and Innate Immune Cells during Breast Cancer Progression. Breast Cancer Research, 9, Article No. 212. https://doi.org/10.1186/bcr1746
|
[49]
|
Vinkemeier, U. (2004) Getting the Message Across, STAT! Design Principles of a Molecular Signaling Circuit. Journal of Cell Biology, 167, 197-201. https://doi.org/10.1083/jcb.200407163
|
[50]
|
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell Jr., J.E. and Kuriyan, J. (1998) Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA. Cell, 93, 827-839. https://doi.org/10.1016/S0092-8674(00)81443-9
|
[51]
|
Darnell Jr., J.E., Kerr, I.M. and Stark, G.R. (1994) Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins. Science, 264, 1415-1421. https://doi.org/10.1126/science.8197455
|
[52]
|
Lee, C.K., Smith, E., Gimeno, R., Gertner, R. and Levy, D.E. (2000) STAT1 Affects Lymphocyte Survival and Proliferation Partially Independent of Its Role Downstream of IFN-Gamma. The Journal of Immunology, 164, 1286-1292. https://doi.org/10.4049/jimmunol.164.3.1286
|
[53]
|
Neunlist, M., Barouk, J., Michel, K., Just, I., Oreshkova, T., Schemann, M., et al. (2003) Toxin B of Clostridium difficile Activates Human VIP Submucosal Neurons, in Part via an IL-1β-Dependent Pathway. American Journal of Physiology: Gastrointestinal and Liver Physiology, 285, G1049-G1055. https://doi.org/10.1152/ajpgi.00487.2002
|
[54]
|
Han, S.Y. and Kim, Y.K. (2019) Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression. The American Journal of Chinese Medicine, 47, 439-455. https://doi.org/10.1142/S0192415X19500228
|
[55]
|
Tzeng, H.E., Tsai, C.H., Ho, T.Y., Hsieh, C.T., Chou, S.C., Lee, Y.J., et al. (2018) Radix Paeoniae Rubra Stimulates Osteoclast Differentiation by Activation of the NF-κB and Mitogen-Activated Protein Kinase Pathways. BMC Complementary Medicine and Therapies, 18, Article No. 132. https://doi.org/10.1186/s12906-018-2196-7
|
[56]
|
Hunter, R.H. (1993) Sperm: Egg Ratios and Putative Molecular Signals to Modulate Gamete Interactions in Polytocous Mammals. Molecular Reproduction and Development, 35, 324-327. https://doi.org/10.1002/mrd.1080350315
|
[57]
|
Keyse, S.M. (2008) Dual-Specificity MAP Kinase Phosphatases (MKPs) and Cancer. Cancer and Metastasis Reviews, 27, 253-261. https://doi.org/10.1007/s10555-008-9123-1
|
[58]
|
Li, Y., Xu, S., Xu, Q. and Chen, Y. (2020) Clostridium difficile Toxin B Induces Colonic Inflammation through the TRIM46/DUSP1/MAPKs and NF-κB Signalling Pathway. Artificial Cells, Nanomedicine, and Biotechnology, 48, 452-462. https://doi.org/10.1080/21691401.2019.1709856
|
[59]
|
Hammer, M., Echtenachter, B., Weighardt, H., Jozefowski, K., Rose-John, S., Mannel, D.N., et al. (2010) Increased Inflammation and Lethality of Dusp1-/- Mice in Polymicrobial Peritonitis Models. Immunology, 131, 395-404. https://doi.org/10.1111/j.1365-2567.2010.03313.x
|
[60]
|
Gil-Araujo, B., Toledo Lobo, M.V., Gutiérrez-Salmerón, M., Gutiérrez-Pitalúa, J., Ropero, S., Angulo, J.C., et al. (2014) Dual Specificity Phosphatase 1 Expression Inversely Correlates with NF-κB Activity and Expression in Prostate Cancer and Promotes Apoptosis through A P38 MAPK Dependent Mechanism. Molecular Oncology, 8, 27-38. https://doi.org/10.1016/j.molonc.2013.08.012
|
[61]
|
Li, X.Y., Liang, J.W., Mohamed, O.K., Zhang, T.J., Lu, G.Q. and Meng, F.H. (2018) Design, Synthesis and Biological Evaluation of N-Phenyl-(2,4-Dihydroxypyrimidine- 5-Sulfonamido) Benzoyl Hydrazide Derivatives as Thymidylate Synthase (TS) Inhibitors and as Potential Antitumor Drugs. European Journal of Medicinal Chemistry, 154, 267-279. https://doi.org/10.1016/j.ejmech.2018.05.020
|
[62]
|
Lu, G.Q., Li, X.Y., Mohamed, O.K., Wang, D. and Meng, F.H. (2019) Design, Synthesis and Biological Evaluation of Novel Uracil Derivatives Bearing 1, 2, 3-Triazole Moiety as Thymidylate Synthase (TS) Inhibitors and as Potential Antitumor Drugs. European Journal of Medicinal Chemistry, 171, 282-296. https://doi.org/10.1016/j.ejmech.2019.03.047
|
[63]
|
Bai, W., Wu, Y., Zhang, P. and Xi, Y. (2015) Correlations Between Expression Levels of Thymidylate Synthase, Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase, and Efficacy of 5-Fluorouracil-Based Chemotherapy for Advanced Colorectal Cancer. International Journal of Clinical and Experimental Pathology, 8, 12333-12345.
|
[64]
|
Jiang, H., Li, B., Wang, F., Ma, C. and Hao, T. (2019) Expression of ERCC1 and TYMS in Colorectal Cancer Patients and the Predictive Value of Chemotherapy Efficacy. Oncology Letters, 18, 1157-1162. https://doi.org/10.3892/ol.2019.10395
|
[65]
|
Torén, W., Ansari, D., Andersson, B., Spelt, L. and Andersson, R. (2018) Thymidylate Synthase: A Predictive Biomarker in Resected Colorectal Liver Metastases Receiving 5-FU Treatment. Future Oncology, 14, 343-351. https://doi.org/10.2217/fon-2017-0431
|
[66]
|
Nagalakshmi, M.L., Rascle, A., Zurawski, S., Menon, S. and De Waal Malefyt, R. (2004) Interleukin-22 Activates STAT3 and Induces IL-10 by Colon Epithelial Cells. International Immunopharmacology, 4, 679-691. https://doi.org/10.1016/j.intimp.2004.01.008
|
[67]
|
Dudakov, J.A., Hanash, A.M. and Van Den Brink, M.R. (2015) Interleukin-22: Immunobiology and Pathology. Annual Review of Immunology, 33, 747-785. https://doi.org/10.1146/annurev-immunol-032414-112123
|
[68]
|
Brandt, M., Grazioso, T.P., Fawal, M.A., Tummala, K.S., Torres-Ruiz, R., Rodriguez-Perales, S., et al. (2018) MTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer But Protects from APC Loss-Dependent Tumorigenesis. Cell Metabolism, 27, 118-135.e8. https://doi.org/10.1016/j.cmet.2017.11.006
|
[69]
|
McGilvray, I.D., Serghides, L., Kapus, A., Rotstein, O.D. and Kain, K.C. (2000) Nonopsonic Monocyte/Macrophage Phagocytosis of Plasmodium Falciparum-Parasitized Erythrocytes: A Role for CD36 in Malarial Clearance. Blood, 96, 3231-3240. https://doi.org/10.1182/blood.V96.9.3231
|
[70]
|
Baranova IN, Kurlander R, Bocharov AV, Vishnyakova TG, Chen Z, Remaley AT, et al. (2008) Role of Human CD36 in Bacterial Recognition, Phagocytosis, and Pathogen-Induced JNK-Mediated Signaling. The Journal of Immunology, 181, 7147-7156. https://doi.org/10.4049/jimmunol.181.10.7147
|
[71]
|
Wullschleger, S., Loewith, R. and Hall, M.N. (2006) TOR Signaling in Growth and Metabolism. Cell, 124, 471-484. https://doi.org/10.1016/j.cell.2006.01.016
|
[72]
|
Düvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., et al. (2010) Activation of A Metabolic Gene Regulatory Network Downstream of MTOR Complex 1. Molecular Cell, 39, 171-183. https://doi.org/10.1016/j.molcel.2010.06.022
|
[73]
|
Bononi, A., Agnoletto, C., De Marchi, E., Marchi, S., Patergnani, S., Bonora, M., et al. (2011) Protein Kinases and Phosphatases in the Control of Cell Fate. Enzyme Research, 2011, Article ID: 329098. https://doi.org/10.4061/2011/329098
|
[74]
|
Yang, K., Shrestha, S., Zeng, H., Karmaus, P.W., Neale, G., Vogel, P., et al. (2013) T Cell Exit from Quiescence and Differentiation into Th2 Cells Depend on Raptor-MTORC1-Mediated Metabolic Reprogramming. Immunity, 39, 1043-1056. https://doi.org/10.1016/j.immuni.2013.09.015
|
[75]
|
Dan, H.C., Cooper, M.J., Cogswell, P.C., Duncan, J.A., Ting, J.P. and Baldwin, A.S. (2008) Akt-Dependent Regulation of NF-κB Is Controlled by MTOR and Raptor in Association with IKK. Genes & Development, 22, 1490-1500. https://doi.org/10.1101/gad.1662308
|
[76]
|
Wang, C., Gao, C. and Li, C. (2020) Expression and Correlation of CDK4 and PD-L1 in Colorectal Cancer Tissues. Journal of Medical Research, 49, 158-162.
|
[77]
|
Dong, X., Wang, J. and Yu, B. (2018) Relationship between the Expression of Geminin, CDK4 and Biological Behaviors of Colorectal Carcinoma. Chinese Journal of Operative Procedures of General Surgery (Electronic Version), 12, 346-348. http://doi.org/10.3877/cma.j.issn.1674-3946.2018.04.024
|
[78]
|
Chapados, B.R., Hosfield, D.J., Han, S., Qiu, J., Yelent, B., Shen, B., et al. (2004) Structural Basis for FEN-1 Substrate Specificity and PCNA-Mediated Activation in DNA Replication and Repair. Cell, 116, 39-50. https://doi.org/10.1016/S0092-8674(03)01036-5
|
[79]
|
Singh, P., Yang, M., Dai, H., Yu, D., Huang, Q., Tan, W., et al. (2008) Overexpression and Hypomethylation of Flap Endonuclease 1 Gene in Breast and Other Cancers. Molecular Cancer Research, 6, 1710-1717. https://doi.org/10.1073/pnas.0813414106
|
[80]
|
McManus, K.J., Barrett, I.J., Nouhi, Y. and Hieter, P. (2009) Specific Synthetic Lethal Killing of RAD54B-Deficient Human Colorectal Cancer Cells by FEN1 Silencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 3276-3281. https://doi.org/10.1016/j.jaci.2015.01.040
|
[81]
|
Mathieu, A.L., Verronese, E., Rice, G.I., Fouyssac, F., Bertrand, Y., Picard, C., et al. (2015) PRKDC Mutations Associated with Immunodeficiency, Granuloma, and Autoimmune Regulator-Dependent Autoimmunity. Journal of Allergy and Clinical Immunology, 135, 1578-1588.e5.
|
[82]
|
Sun, S., Cheng, S., Zhu, Y., Zhang, P., Liu, N., Xu, T., et al. (2016) Identification of PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide) as an Essential Gene for Colorectal Cancer (CRCs) Cells. Gene, 584, 90-96. https://doi.org/10.1016/j.gene.2016.03.020
|
[83]
|
Lu, Y., Zhang, H.L., Li, Y.Z. and Zhao, P. (2008) Clinicopathological Significance of Expressions of DNA Dependent Protein Kinase Catalytic Subunit and P16 in Colorectal Carcinoma. National Medical Journal of China, 88, 2025-2029.
|
[84]
|
Davidson, D., Coulombe, Y., Martinez-Marignac, V.L., Amrein, L., Grenier, J., Hodkinson, K., et al. (2012) Irinotecan and DNA-PKcs Inhibitors Synergize in Killing of Colon Cancer Cells. Investigational New Drugs, 30, 1248-1256. https://doi.org/10.1007/s10637-010-9626-9
|
[85]
|
Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., et al. (2013) Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients. Microbial Ecology, 66, 462-4670. https://doi.org/10.1007/s00248-013-0245-9
|
[86]
|
Kostic, A.D., Gevers, D., Pedamallu, C.S., Michaud, M., Duke, F., Earl, A.M., et al. (2012) Genomic Analysis Identifies Association of Fusobacterium with Colorectal Carcinoma. Genome Research, 22, 292-298. https://doi.org/10.1101/gr.126573.111
|
[87]
|
Li, S., Liu, H., Xin, Y., Wang, L., Fu, S., Ma, L., et al. (2018) Correlation between Clostridium difficile Infection and Colorectal Cancer and Colorectal Adenoma. Chinese Journal of Microecology, 30, 300-303.
|